Cancer Cure in Sight

In a bold vision for the future of medicine, Joaquin Duato, CEO of Johnson & Johnson, declared cancer could be eliminated within ten years, citing breakthroughs like immune-based therapies that’ve turned once-fatal multiple myeloma into a manageable decade-long condition. Patients now live in remission for years after a single treatment—far from the grueling hospital routines of the past. J&J is accelerating research and acquiring cutting-edge firms like Firefly Bio to target hard-to-treat mutations. Dr. Marc Siegel adds AI will revolutionize cancer care by personalizing treatments and early detection, while both leaders stress that as longevity tech advances, diseases like dementia and cancer will shift from terminal to chronic—ushering in a new era of health where life expectancy and quality of life soar. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/9ca6c0ec58e7dd90